Regulus Therapeutics
RGLS
#8849
Rank
โ‚น7.74 B
Marketcap
โ‚น118.27
Share price
0.00%
Change (1 day)
1.39%
Change (1 year)

Revenue for Regulus Therapeutics (RGLS)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Regulus Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚น0.73 B50.2%
2019 โ‚น0.48 B9577.32%
2018 โ‚น5.03 M9.51%
2017 โ‚น4.59 M-94.33%
2016 โ‚น81.13 M-94.12%
2015 โ‚น1.37 B183.83%
2014 โ‚น0.48 B-59.8%
2013 โ‚น1.20 B73.86%
2012 โ‚น0.69 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น3.400 TN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น4.520 TN/A๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น817.09 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.150 TN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น176.96 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.03 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.007 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น16.29 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA